Letters Guideline treatments in complex multimorbidity

Authors’ reply to Devitt

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6331 (Published 25 November 2015) Cite this as: BMJ 2015;351:h6331
  1. Christiane Muth, senior researcher1,
  2. Paul P Glasziou, professor of evidence based medicine2
  1. 1Institute of General Practice, Johann Wolfgang Goethe University, Frankfurt, Germany
  2. 2Centre for Research in Evidence-Based Practice, Bond University, Robina, Qld, Australia
  1. muth{at}allgemeinmedizin.uni-frankfurt.de

Although our example of the dilemma of prescribing β blockers in asthma was a little outmoded,1 2 recent summaries of products characteristics, including those for metoprolol, bisoprolol, propranolol, and nebivolol, state that these …

View Full Text

Log in

Log in through your institution


* For online subscription